Ticker: FULC

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Overview Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for genetically defined rare diseases. The company's key product candidate is pociredir, which is under clinical development for treating sickle ce...